Mosapride citrate tablets are not a quadruple combination drug. Quadruple drug refers to a proton pump inhibitor plus two antibiotics plus a bismuth agent, which is commonly used in clinical practice for the eradication of Helicobacter pylori, in which the proton pump inhibitor can be chosen from omeprazole, pantoprazole, etc., the antibiotics can be chosen from furacilin, metronidazole, clarithromycin, etc., and the bismuth agent commonly used are bismuth potassium citrate, bismuth pectin, etc.. Mosapride citrate is a digestive tract prokinetic agent, belonging to the selective 5 hydroxytryptamine 4 receptor agonist, through the excitation of gastrointestinal tract cholinergic interneurons and interosseous plexus of 5 hydroxytryptamine 4 receptor, to promote the release of acetylcholine, so as to enhance the movement of the upper gastrointestinal tract (stomach and small intestine), to improve the gastrointestinal symptoms of patients with functional dyspepsia. Mosapride Citrate is mainly used for functional dyspepsia with heartburn, belching, nausea, vomiting, early satiety and other digestive symptoms; it can also be used for gastroesophageal reflux disease, diabetic gastroparesis and gastric dysfunction in patients with partial gastrectomy. Children, pregnant women, elderly patients should be used with caution; allergic to the product is prohibited. Mosapride Citrate should be taken under medical supervision.